It was reported that glucocorticoid-activated TEAD4 promoted maintenance, metastasis, and chemoresistance of breast cancer stem cells, high expression of TEAD4 predicted a poor outcome in breast cancer patients [34]. Here, TEAD4 is linked to breast cancer.